ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,612.03
-0.32%
S&P 500
5,473.17
-0.25%
Dow Jones
39,134.76
0.77%
US Dollar vs Yen
158.8975
-0.02%
Brent Oil
84.99
-0.02%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Pacira BioSciences Inc (PCRX)

  7. Pacira BioSciences Inc (PCRX) ニュース

PCRX

Pacira BioSciences (PCRX)

Pacira BioSciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PCRX
日付受信時刻ニュースソース見出しコード企業名
2024/06/1407 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1407 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1407 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1407 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1407 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1407 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1407 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1407 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1407 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1407 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1407 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1406 : 14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
2024/06/1323 : 19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1305 : 23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/1200 : 46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/0606 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/0606 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/0606 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/06/0606 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
2024/05/3021 : 00GlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
2024/05/1505 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
2024/05/1020 : 00GlobeNewswire Inc.Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029NASDAQ:PCRXPacira BioSciences Inc
2024/05/0905 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
2024/05/0905 : 05GlobeNewswire Inc.Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior NotesNASDAQ:PCRXPacira BioSciences Inc
2024/05/0805 : 02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCRXPacira BioSciences Inc
2024/05/0805 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
2024/05/0805 : 00GlobeNewswire Inc.Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase programNASDAQ:PCRXPacira BioSciences Inc
2024/05/0721 : 00GlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
2024/04/3021 : 00GlobeNewswire Inc.Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024NASDAQ:PCRXPacira BioSciences Inc
2024/04/0221 : 00GlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:PCRX

最近閲覧した銘柄

BIT
UC41HC
Unicredit Bank
BITMOT
973318
Oat Tf 2,5% St26 Eur
NYSE
C-W.CL
BIT
P1Z6H4
NLBNPIT1Z6H4 20991231 3....
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有